ID 4690 -
Kwas eikozapentaenowy
PL: Kwas eikozapentaenowy
EN: Eicosapentaenoic acid (EPA)
Pdf: eicosapentaenoic acid
Oświadczenie (2)
- immunomodulujące agent
- immunomodulujące agent powodu EPA i DHA
1. Charakterystyka żywności / składnika
The food constituent which is the subject of the health claims is mixed long-chain n-3 polyunsaturated fatty acids (n-3 LCPUFA), namely docosahexaenoic acid (DHA) in combination with eicosapentaenoic acid (EPA) and, for ID 703, with docosapentaenoic acid (DPA).
The n-3 LCPUFA EPA, DHA and DPA are recognised nutrients and are measurable in foods by established methods. They are well absorbed when consumed in the form of triglycerides. This evaluation applies to EPA, DHA and, for ID 703, DPA from all sources with suitable bioavailability in the specified amounts.
The Panel considers that the food constituent, EPA, DHA and DPA, which is the subject of the health claims, is sufficiently characterised.
2.10. Czynnik wpływający na odpowiedź immunologiczną (ID 4690)
The claimed effect is “immunomodulating agent due to EPA and DHA”. The Panel assumes that the target population is the general population.
“Immunomodulating agent” is not sufficiently defined and no further details are given in the proposed wording. In the references, that were cited for the scientific substantiation of the claimed effect several effects were mentioned (related for example to coronary heart disease, rheumatoid arthritis, asthma or eczema) and it is not possible to establish which specific effect is the target for the claim.
In the absence of such information, the Panel considers that the claimed effect is not sufficiently defined for a scientific evaluation.
The Panel considers that the claimed effect is general and non-specific and does not refer to any specific health claim as required by Regulation (EC) No 1924/2006.
Warunki i możliwe ograniczenia stosowania oświadczenia